Local view for "http://purl.org/linkedpolitics/eu/plenary/2009-05-04-Speech-1-064"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2009-05-04"^^xsd:date2
dcterms:Is Part Of	lp_eu:Flu epidemic (debate)2
dcterms:Language	"nl"^^xsd:language2
lpv:document identification number	"en.20090504.15.1-064"2
lpv:hasSubsequent	lp_eu:2009-05-04-Speech-1-0652
lpv:speaker	lp:Bart Staes2
lpv:spokenAs	substitute; Delegation to the EU-Kazakhstan, EU-Kyrgyzstan and EU-Uzbekistan Parliamentary Cooperation Committees, and for relations with Tajikistan, Turkmenistan and Mongolia (2004-09-15--2009-07-13)3 unknown; Groen (2004-07-20--2009-07-13)3 member; G/EFA (2004-07-20--2009-07-13)3 substitute; ENVI (2007-01-31--2009-07-13)3 member; Delegation to the EU-Russia Parliamentary Cooperation Committee (2004-09-15--2009-07-13)3 substitute; REGI (2007-01-31--2009-07-13)3 member; CONT (2007-01-31--2009-07-13)3
lpv:translated text	". Mr President, ladies and gentlemen, I should like to join those who have thanked you, Commissioner, for the comprehensive information you have given us. Yet I agree with Mr Trakatellis and Mr Maaten. We did hold an extensive debate in this House in June 2006. We adopted a resolution, on which we worked hard at the time in Parliament’s Committee on the Environment, Public Health and Food Safety. I have looked again at that resolution and I must say that, like Mr Trakatellis, I fear that there are a great many gaps, many weaknesses in the current approach. Back then, we strongly recommended ensuring an exchange of information and also constructive cooperation between Member States, with a coordinating role for the Commission and in constructive cooperation with the European Centre for Disease Prevention and Control. Anyone who now takes a good look round – and Mr Maaten raised this point very emphatically – will see that there are a great many gaps, that things are going incredibly slowly. As for the stockpiles of antiviral drugs; you yourself told us a few days ago that stocks were sufficient to cover 16% of the population, when we had said that the figure needed to be 30%. Therefore, things are well below par, not to mention as regards the exchange of information on the nature of the virus. This exchange of information is essential, as vaccines cannot be developed unless the nature of the virus is known. Scientists I have contacted in recent days say that they have no information, that they cannot get hold of any. Information on the nature of the virus is protected, is kept secret. We have all these research institutes, but we cannot do what we need to do. Something must be done about this. We cannot tolerate this; the threat is really too great."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph